Categories: Business

Arasan MIPI DSI-2 Rx Controller achieves ISO 26262 ASIL-B Certification

Arasan Chip Systems, a leading provider of semiconductor IP for automobile SoCs, today announced that its MIPI DSI-2 Rx IP has achieved ISO26262 ASIL-B automotive certification

- Advertisement -

SAN JOSE, Calif., Aug. 26, 2025 /PRNewswire/ — Arasan Chip Systems, a leading provider of semiconductor IP for mobile and automobile SoCs, today announced the immediate availability of its ISO26262 ASIL-B Certified MIPI DSI-2 Rx Controller for mobile and automobile SoCs. The certification applies to the latest generation of Arasan’s MIPI DSI IP.

- Advertisement -

The ISO26262 ASIL-B certification signifies that Arasan’s DSI-2 Rx Controller meets the stringent safety requirements for automotive System-On-Chips (SoCs). Additionally, the certification extends its usability to defense, aircraft, and other industries that require failsafe operation.

- Advertisement -

Arasan’s Total Display IP Solution comprises of Arasan’s VESA DSC Encoder IP, VESA Decoder IP, Arasan DSI Tx & Rx IP for Low resolution displays like those found on IoT devices and wearables like fitness bands, sensors and smartwatches, Arasan DSI-2 Tx & Rx IP for Hi-Resolution displays with both versions of its MIPI Display IP seamlessly integrated with our MIPI D-PHY IP or C/D-PHY Combo IP. Arasan offers an ultra low power consumption D-PHY IP operating at 1.5gig specifically targeting the wearables market for use with its DSI IP.

- Advertisement -

Arasan also offers its ASIL-C certified CAN 2.0 IP, CAN FD IP and CAN XP IP in addition to its LIN IP and Ethernet Controller IP core as part of its automotive IP offering.

- Advertisement -

A demonstration of of Arasan’s MIPI DSI-2 IP seamlessly integrated with our C/D-PHY Combo ASIC on a MIPI Compliance Tester can be found here:

- Advertisement -

https://youtu.be/lmC50LjFwXQ?si=pDxISVdMZL1blya9

- Advertisement -

More information on Arasan DSI-2 Rx Controller IP can be found here:

- Advertisement -

https://www.arasan.com/products/mipi/dsi/dsi-2-rx/

- Advertisement -

Availability

- Advertisement -

The Arasan MIPI DSI-2 Rx Controller IP is available immediately for ASIC and FPGA applications. Please contact bonnie.noufer@arasan.com for product enquiries.

- Advertisement -

Media Contact:
Bonnie Noufer
bonnie.noufer@arasan.com 

- Advertisement -

About Arasan:
Arasan Chip Systems is a leading provider of IP for mobile storage and mobile connectivity interfaces, with over a billion chips shipped with our IP. Our high-quality, silicon-proven Total IP Solutions encompass digital IP, Analog Mixed Signal PHY IP, Verification IP, HDK, and Software. With a strong focus on mobile SoCs, we have been at the forefront of the Mobile evolution since the mid-90s, supporting various mobile devices, including smartphones, automobiles, drones, and IoT devices, with our standards-based IP.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2756429/DSI2RX_ASIL_Certification_001.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2724571/5473449/Arasan_Chip_Systems_Inc_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/arasan-mipi-dsi-2-rx-controller-achieves-iso-26262-asil-b-certification-302537028.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

2 weeks ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

3 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

4 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

2 months ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

2 months ago